Page last updated: 2024-12-08

vincristine sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5388992
CHEMBL ID385978
MeSH IDM0022677
PubMed CID249332
CHEMBL ID501867
CHEBI ID79401
SCHEMBL ID3710
MeSH IDM0022677

Synonyms (112)

Synonym
MLS001148250
vincasar pfs
ai3-52944
einecs 218-190-0
vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt)
ccris 2583
vincristinsulfat [german]
vincristine sulfate, meets usp testing specifications
MLS000863277 ,
smr000058540
MLS000069706 ,
vincristine sulfate salt
MLS001401434
vincristine sulfate salt, 95.0-105.0% (hplc), powder
HMS2052D03
vincristine sulfate [usan:usp:jan]
unii-t5iro3534a
vincristine sulfate liposomes injection
t5iro3534a ,
vincristinsulfat
HMS2234B06
CCG-101152
vincristine sulfate [ep monograph]
vincristini sulfas [who-ip latin]
vincristine sulfate [orange book]
vincristine sulfate [vandf]
vincristine sulfate [mi]
vincristine sulfate [usan]
22-oxovincaleukoblastine sulfate (1:1) (salt) [who-ip]
vincristine sulfate [usp monograph]
vincristine sulfate [iarc]
vincristine sulfate [mart.]
vincristine sulfate [who-ip]
vincristine sulfate [usp-rs]
vincristine sulfate [who-dd]
vincristine sulfate [jan]
HY-N0488
vincristine (sulfate)
CS-1778
NC00402
Q-201925
OPERA_ID_836
AKOS030497863
vincristine sulfate (assay), united states pharmacopeia (usp) reference standard
vincristine sulfate, united states pharmacopeia (usp) reference standard
vincristine sulfate, european pharmacopoeia (ep) reference standard
vincristine sulfate (assay)
Q27095645
AS-12168
vincaleukoblastine, 22-oxo-, sulfate (1:1)
vcr . sulfate;leukocristine . sulfate
CHEMBL385978
V0129
vincristine sulfate pfs
vincrex
nsc-67574
vcr sulfate
LCR ,
nsc 67574
kyocristine
leurocristine sulfate (1:1) (salt)
leurocristine sulfate
lilly 37231
leurocristine, sulfate
leurocristine sulfate (1:1)
vincrisul
onkovin
vincristine, sulfate
oncovin (lilly)
leurocristine, sulfate (1:1) (salt)
NSC67574 ,
vincristine sulfate (jp17/usp)
vincrex (tn)
marqibo (tn)
D02197
oncovin (tn)
vincasar (tn)
sulfate, vincristine
22-oxovincaleukoblastine sulfate
marqibo kit
AKOS015895862
vincristini sulfas
vincristine sulfate liposome
CHEMBL501867
lilly-37231
novopharm
chebi:79401 ,
AQTQHPDCURKLKT-JKDPCDLQSA-N
SCHEMBL3710
DTXSID8044331 ,
mfcd08706469
methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indol
HMS3678L11
HMS3414L13
rel-vincristine sulfate
1217704-93-2
leurocristine (sulfate);nsc-67574 (sulfate);22-oxovincaleukoblastine (sulfate)
A936684
vincristine sulphate salt
methyl (3ar,4r,5s,5ar,10br,13ar)-4-acetoxy-3a-ethyl-9-((5s,7r,9s)-5-ethyl-5-hydroxy-9-methoxycarbonyl-1,4,5,6,7,8,9,10-octahydro-3,7-methano-3-azacycloundecino(5,4-b)indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,4,5,5a,6,11,12,13a-octahydro-1h-indolizino(8,
dtxcid6024331
vincristine sulfate (ep monograph)
vincristine sulfate (usp monograph)
leurocristine sulphate
22-oxovincaleukoblastine sulfate (1:1) (salt)
vincosid
des-na-methyl-na-formylvinblastine sulphate
vcr sulphate
vincristine sulfate (iarc)
vincristine sulfate (mart.)
vincristine sulfate (usp-rs)
lcr sulphate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic sulfate salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency10.00000.044717.8581100.0000AID485341
ATAD5 protein, partialHomo sapiens (human)Potency1.45750.004110.890331.5287AID504466
TDP1 proteinHomo sapiens (human)Potency0.14580.000811.382244.6684AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency35.48130.180013.557439.8107AID1460
Smad3Homo sapiens (human)Potency0.79430.00527.809829.0929AID588855
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency0.06310.00137.762544.6684AID914; AID915
67.9K proteinVaccinia virusPotency1.99740.00018.4406100.0000AID720579; AID720580
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency44.66840.707936.904389.1251AID504333
IDH1Homo sapiens (human)Potency1.29950.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency28.18380.035520.977089.1251AID504332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency24.92710.036619.637650.1187AID2100
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency0.89130.01262.451825.0177AID485313
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.25930.00419.984825.9290AID504444
ras-related protein Rab-9AHomo sapiens (human)Potency0.08910.00022.621531.4954AID485297
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency19.95260.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency0.44120.004611.374133.4983AID624296; AID624297
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency0.02820.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)IC50 (µMol)0.27790.13430.86462.1450AID687017
steroidogenic factor 1Homo sapiens (human)IC50 (µMol)67.54101.87302.92953.9860AID687018
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)133.00000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)133.00000.20005.677410.0000AID1473741
Bile salt export pumpHomo sapiens (human)IC50 (µMol)133.00000.11007.190310.0000AID1473738
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (41)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (24)

Processvia Protein(s)Taxonomy
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (279)

Assay IDTitleYearJournalArticle
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
AID1127357Cytotoxicity against human colon cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID718280Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID340794Cytotoxicity against human ovarian cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID1127362Cytotoxicity against human breast cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID1147798Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID347110Antitumor activity against human Melanoma cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID1428467Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID347112Antitumor activity against human renal cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID291350Antitumor activity against renal tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID245793Total growth inhibition of human Breast cell line at 10E-3 M concentration 2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID499209Growth inhibition of human prostate cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID735323Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Bromotyrosine alkaloids from the Australian marine sponge Pseudoceratina verrucosa.
AID499202Growth inhibition of human leukemia cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID1147751Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.22 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID340798Cytotoxicity against human leukemia cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID272811Anticancer activity against renal cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID272805Anticancer activity against leukemia cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID1127360Cytotoxicity against human renal cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1124082Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID524792Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID247446Growth inhibitory concentration dissolved in DMSO against human Melanoma cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1124104Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as increase in host lifespan at 1.5 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID340791Cytotoxicity against human colon cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID245800Total growth inhibition of human Ovarian cell line at 10E-3 M concentration 2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1147766Toxicity in ip dosed mouse allografted with mouse p388 cells after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID272810Anticancer activity against ovarian cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID1147785Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID718278Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID480513Growth inhibition of human renal cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID245802Total growth inhibition of human Prostate cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID146686Inhibition of proliferation in NCI human non-small cell lung tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID247631Cytotoxic activity against human tumor C8305 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID499206Growth inhibition of human melanoma cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID247450Growth inhibitory concentration dissolved in DMSO against human leukemia cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1147835Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 0.22 mg/kg/day administered from day 1 to day 91978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID286653Cytotoxicity against human SMMC7721 cells after 48 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Cytotoxic germacranolides and acyclic diterpenoides from the seeds of Carpesium triste.
AID499205Growth inhibition of human CNS cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID675712Cytotoxicity against human prostate cancer cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID347113Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID1147794Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID675708Cytotoxicity against human CNS cancer cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID1147825Acute toxicity in rat1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID247436Growth inhibitory concentration dissolved in DMSO against human NSCLC cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID340797Cytotoxicity against human breast cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID245787Total growth inhibition of human NSCLC cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID480510Growth inhibition of human CNS cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID480511Growth inhibition of human melanoma cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID1147765Toxicity in ip dosed mouse allografted with mouse p388 cells administered from day 1 to day 91978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID340795Cytotoxicity against human renal cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID247442Growth inhibitory concentration dissolved in DMSO against human MG-MID cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID347108Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID347111Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID247603Cytotoxic activity against human tumor Aro cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1401832Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID347107Antitumor activity against human NSCLC cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID247660Cytotoxic activity against human tumor Igrov-1 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID499207Growth inhibition of human Ovarian cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID499208Growth inhibition of human renal cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID516589Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Chemical investigation of drug-like compounds from the Australian tree, Neolitseadealbata.
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1124080Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.67 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID480508Growth inhibition of human NSCLC cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID1147736Toxicity in ip dosed mouse allografted with mouse P1534(J) cells administered from day 1 to day 91978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1428466Antiproliferative activity against human HGC27 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID222034Cytostatic effect on human melanoma tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID291345Antitumor activity against leukemia cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID219003Inhibition of proliferation in NCI human breast tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1147760Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.8 mg/kg/day, ip after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID223655Cytostatic effect on human prostate tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID675709Cytotoxicity against human melanoma cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID347114Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID1147828Neurotoxicity in iv dosed monkey assessed as peripheral neuropathy1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID247633Cytotoxic activity against human tumor MCF-7 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1147749Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.33 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1127358Cytotoxicity against human melanoma cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID1127363Cytotoxicity against human CNS cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID1127359Cytotoxicity against human ovarian cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID272809Anticancer activity against melanoma cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID718282Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID219716Inhibition of proliferation in NCI human colon tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID272806Anticancer activity against NSCLC cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID1124091Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1127361Cytotoxicity against human prostate cancer cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID1147723Antitumor activity against mouse Gardner lymphosarcoma cell allografted in mouse at 0.1 to 0.2 mg/kg/day, ip1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID291346Antitumor activity against NSCLC cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID223611Cytotoxic effect on human ovarian tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID272812Anticancer activity against prostate cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID1127356Cytotoxicity against human NSCLC cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID247715Cytotoxic activity against human tumor Mia Paca 2 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1124099Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as day of host death at 1.5 mg/kg, ip administered on days 1, 5 and 9 (Rvb = 10 days)1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID249141Cytotoxic effect dissolved in DMSO against Leukemia cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID340792Cytotoxicity against human central nervous system cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID735328Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Bromotyrosine alkaloids from the Australian marine sponge Pseudoceratina verrucosa.
AID272813Anticancer activity against breast cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID1147768Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID223654Inhibition of proliferation in NCI human prostate tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID347106Antitumor activity against human Leukemia cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID340796Cytotoxicity against human prostate cancer cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID1262236Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
AID718283Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID675710Cytotoxicity against human ovarian cancer cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID146689Cytostatic effect on human non-small cell lung carcinoma tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1147784Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID99410Cytotoxic effect on human leukemia tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1124087Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID247431Growth inhibitory concentration dissolved in DMSO against human CNS cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1124108Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.002 ug/ml1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID675706Cytotoxicity against human NSCLC cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID340790Cytotoxicity against human Non-small cell lung carcinoma cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID480515Growth inhibition of human breast cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID524794Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1147776Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1147727Acute toxicity in ip dosed mouse1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1124088Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1147796Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1127355Cytotoxicity against human leukemia cells after 48 hrs2014European journal of medicinal chemistry, May-22, Volume: 79Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
AID219717Cytotoxic effect on human colon tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1124081Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID219005Cytostatic effect on human breast tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID291349Antitumor activity against melanoma cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID675713Cytotoxicity against human breast cancer cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID247448Growth inhibitory concentration dissolved in DMSO against human Prostate cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID499203Growth inhibition of human NSCLC cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID1147740Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.2 mg/kg/day after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID524795Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID249131Cytotoxic effect dissolved in DMSO against NSCLC cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1124107Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.02 ug/ml1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID291352Antitumor activity against ovarian tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID228572Cytotoxic effect on 60 human tumor cell line panel, MG-MID represents mean value2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID228383Cytotoxic effect on human renal tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID480514Growth inhibition of human prostate cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID1262238Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
AID675711Cytotoxicity against human renal cancer cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID106502Inhibition of proliferation in NCI 60 human tumor cell line panel, MG-MID represents mean value2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1401833Cytotoxicity against human HGC27 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID1147748Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID347109Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
AID1147731Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.8 mg/kg/day after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID291351Antitumor activity against prostate tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID247691Cytotoxic activity against human tumor PLC/PRF/5 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1428461Antiproliferative activity against human A549 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID1147797Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID340793Cytotoxicity against human melanoma cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Antitumor activity of bis-indole derivatives.
AID247672Cytotoxic activity against human tumor NCI-H295 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID499204Growth inhibition of human colon cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID228382Inhibition of proliferation in NCI human renal tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID499210Growth inhibition of human breast cancer cells after 48 hrs2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells.
AID247634Cytotoxic activity against human tumor SW 13 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1401834Cytotoxicity against human NCI-H460 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID1124089Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID223612Cytostatic effect on human ovarian tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1147775Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID291353Antitumor activity against breast tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID249122Cytotoxic effect dissolved in DMSO against CNS cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID291347Antitumor activity against colon tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID1124083Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID247632Cytotoxic activity against human tumor HT-29 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID245783Total growth inhibition of human CNS cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID675707Cytotoxicity against human COLON cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID249143Cytotoxic effect dissolved in DMSO against Melanoma cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1124109Displacement of [3H]VLB from tubulin in pig brain by competitive assay1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID718281Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID219004Cytotoxic effect on human breast tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1401837Cytotoxicity against mouse 4T1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID480509Growth inhibition of human colon cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID1147788Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1147777Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID222029Inhibition of proliferation in NCI human melanoma tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID247661Cytotoxic activity against human tumor Ovcar-3 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID247440Growth inhibitory concentration dissolved in DMSO against human Breast cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID249145Cytotoxic effect dissolved in DMSO against Prostate cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1147827Neurotoxicity in iv dosed monkey assessed as leukopenia1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID146687Cytotoxic effect on human non-small cell lung carcinoma cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1428465Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID1147761Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.2 mg/kg/day, ip after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID45935Inhibition of proliferation in NCI human CNS tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1428460Antiproliferative activity against human BT549 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID249133Cytotoxic effect dissolved in DMSO against Renal cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1124065Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.10 mg/kg, ip administered daily for 8 to 10 days1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID480507Growth inhibition of human leukemia cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID161368Cytotoxic effect on human prostate tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID524791Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1428462Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID272807Anticancer activity against colon cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID249139Cytotoxic effect dissolved in DMSO against Ovarian cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID272808Anticancer activity against CNS cancer cell lines of NCI60 panel2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
AID245785Total growth inhibition of human Colon cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID245798Total growth inhibition of human Melanoma cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID247646Cytotoxic activity against human tumor Hep G2 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1428464Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID52655Cytostatic effect on human colon tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID245789Total growth inhibition of human Renal cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID99407Inhibition of proliferation in NCI human leukemia tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1147778Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID247612Cytotoxic activity against human tumor PT45 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID106503Cytostatic effect on 60 human tumor cell line panel, MG-MID represents mean value2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID675705Cytotoxicity against human leukemia cells after 48 hrs2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action.
AID286655Cytotoxicity against human L02 cells after 48 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Cytotoxic germacranolides and acyclic diterpenoides from the seeds of Carpesium triste.
AID1147719Antitumor activity against mouse Ridgeway osteogenic sarcoma cells allografted in mouse at 0.1 to 0.2 mg/kg/day, ip1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID45936Cytotoxic effect on human CNS tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1124112Cytotoxicity against CHO cells at 0.02 ug/ml1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID247444Growth inhibitory concentration dissolved in DMSO against human Ovarian cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1147767Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1147732Antitumor activity against mouse P1534(J) cells allografted in mouse assessed as tumor growth inhibition at 0.25 mg/kg/day, ip administered from day 1 to day 9 relative to unreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID223610Inhibition of proliferation in NCI human ovarian tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID249137Cytotoxic effect dissolved in DMSO against MG-MID cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID524796Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1124094Toxicity in CD2F1 mouse allografted with mouse P388/VCR cells at 1.67 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1401838Cytotoxicity against human RWPE1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID735326Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Bromotyrosine alkaloids from the Australian marine sponge Pseudoceratina verrucosa.
AID1124090Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.90 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID480512Growth inhibition of human ovarian cancer cell by NCI-CLS assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Antitumor activity and COMPARE analysis of bis-indole derivatives.
AID1428463Antiproliferative activity against mouse 4T1 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1124075Toxicity in iv dosed mouse assessed as lethality1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1147774Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID286654Cytotoxicity against human HL60 cells after 48 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Cytotoxic germacranolides and acyclic diterpenoides from the seeds of Carpesium triste.
AID1147786Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1124066Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.20 mg/kg, ip administered daily for 8 to 10 days1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID249129Cytotoxic effect dissolved in DMSO against Colon cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1401836Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
AID249135Cytotoxic effect dissolved in DMSO against Breast cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID524790Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID247645Cytotoxic activity against human tumor Hep 3B cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID247630Cytotoxic activity against human tumor A-172 cell line2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
AID1147795Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID291348Antitumor activity against CNS tumor cells2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
AID245791Total growth inhibition of human MG-MID cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID45937Cytostatic effect on human CNS tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID516590Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Chemical investigation of drug-like compounds from the Australian tree, Neolitseadealbata.
AID99411Cytostatic effect on human leukemia tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID228384Cytostatic effect on human renal tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID1147758Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 4 mg/kg/day, ip after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1262235Cytotoxicity against human KB cells after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
AID1147745Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1262237Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
AID1147826Neurotoxicity in iv dosed chicken assessed as neuromuscular disturbance by measuring loss of balance1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1124086Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 91979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1124067Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered daily for 8 to 10 days1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
AID1147747Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID247438Growth inhibitory concentration dissolved in DMSO against human Renal cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID245796Total growth inhibition of human Leukemia cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID524793Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1147759Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 2.7 mg/kg/day, ip after 1 day1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID1147787Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
AID222031Cytotoxic effect on human melanoma tumor cell lines2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID718279Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi.
AID247433Growth inhibitory concentration dissolved in DMSO against human Colon cell line at 10E-3 M concentration2005Journal of medicinal chemistry, Aug-25, Volume: 48, Issue:17
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
AID1401835Cytotoxicity against human DU145 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.25)18.7374
1990's0 (0.00)18.2507
2000's11 (34.38)29.6817
2010's18 (56.25)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.01 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index88.96 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (56.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]